Laura Prakash

Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…

Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…

LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM

Early loss of mesoportal venous patency after reconstruction during pancreatectomy is often due to technical factors, whereas delayed loss is often associated with disease recurrence…

Formerly validated risk-stratified pancreatectomy clinical pathways decreased index hospitalization stay without increasing readmissions, which remain major contributors to the financial burden of pancreatectomy…

BACKGROUND: Risk-stratified pancreatectomy clinical pathways (RSPCP) are associated with reduced length of stay (LOS) and major complications…